Literature DB >> 21805735

[Expert consensus on the scheme of pathological diagnosis of primary liver cancer].

.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21805735

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN： 1007-3418


× No keyword cloud information.
  6 in total

1.  A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.

Authors:  Ying Shi; Junwei Wang; Yuhe Wang; Anna Wang; Hongliang Guo; Feili Wei; Sanjay R Mehta; Stephen Espitia; Davey M Smith; Longgen Liu; Yulin Zhang; Dexi Chen
Journal:  Cancer Lett       Date:  2015-12-17       Impact factor: 8.679

2.  Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.

Authors:  Mingjie Yao; Jingmin Zhao; Fengmin Lu
Journal:  Oncotarget       Date:  2016-01-26

3.  Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

Authors:  Tianhui Liu; Mingjie Yao; Shuhong Liu; Lu Wang; Leijie Wang; Jinlin Hou; Xiong Ma; Jidong Jia; Jingmin Zhao; Hui Zhuang; Fengmin Lu
Journal:  Oncotarget       Date:  2017-03-07

4.  Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma.

Authors:  Xinping Ye; Guanghui Li; Chuangye Han; Quanfa Han; Liming Shang; Hao Su; Bowen Han; Yizhen Gong; Guodong Lu; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-11-15       Impact factor: 3.989

5.  Determination of Endogenous Bufalin in Serum of Patients With Hepatocellular Carcinoma Based on HPLC-MS/MS.

Authors:  Mengfei Han; Geliang Yang; Qing Lin; Yanlong Yang; Huiqing Zhang; Yonghua Su
Journal:  Front Oncol       Date:  2020-01-23       Impact factor: 6.244

6.  Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.

Authors:  Jian Gao; Rui Zhen; Hai Liao; Wenquan Zhuang; Wenbo Guo
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.